In conclusion, urinary micro-peptides [Catalase, α-1 Acid Glycoprotein and Peroxiredoxin-2] can be useful biomarkers for early detection and treatment response monitoring of ovarian cancer. The gene discussed is PRDX2; the disease is ovarian carcinoma.